Table 1 Participant characteristics in all participants and by drug. Data are shown as mean ± standard deviation or percentage
Total | Citalopram | Fluoxetine | Paroxetine | Sertraline | p-value* | |
|---|---|---|---|---|---|---|
N = 663 | N = 202 | N = 191 | N = 107 | N = 163 | ||
Demographics | ||||||
Age, years | 61 (46 – 72) | 51 (40 – 66) | 65 (53 – 76) | 59 (48 – 69) | 64 (46 – 77) | < 0.001 |
Gender, females | 507 (76%) | 158 (78%) | 151 (79%) | 80 (75%) | 118 (72%) | 0.44 |
Race, White | 621 (94%) | 190 (94%) | 181 (95%) | 100 (93%) | 150 (92%) | 0.79 |
Anthropometrics | ||||||
Weight, kg | 78.0 (65.3 – 94) | 76.2 (64.3 – 91.1) | 82.0 (69.7 – 97) | 74.2 (62 – 92.7) | 76.7 (65 – 93.7) | 0.03 |
BMI, kg/m2 | 27.8 (24.0 – 32.9) | 27.2 (23.6 – 32.1) | 30.0 (25.1 – 34.4) | 26.3 (23.8 – 32.5) | 27.7 (23.7 – 32.5) | 0.009 |
BMI Class | ||||||
Class, underweight or normal weight | 211 (32%) | 61(30%) | 46 (24%) | 45 (35%) | 59 (36%) | |
Class, overweight | 202 (30%) | 79 (39%) | 48 (25%) | 25 (23%) | 50 (31%) | |
Class, obesity | 250 (38%) | 62 (31%) | 97 (51%) | 37 (42%) | 52 (33%) | |